SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Witjes J Alfred)
 

Search: WFRF:(Witjes J Alfred) > (2010-2014) > ICUD-EAU Internatio...

ICUD-EAU International Consultation on Bladder Cancer 2012: Non-Muscle-Invasive Urothelial Carcinoma of the Bladder

Burger, Maximilian (author)
Oosterlinck, Willem (author)
Konety, Badrinath (author)
show more...
Chang, Sam (author)
Gudjonsson, Sigurdur (author)
Lund University,Lunds universitet,Urologi,Forskargrupper vid Lunds universitet,Urology,Lund University Research Groups
Pruthi, Raj (author)
Soloway, Mark (author)
Solsona, Eduardo (author)
Sved, Paul (author)
Babjuk, Marko (author)
Brausi, Maurizio A. (author)
Cheng, Christopher (author)
Comperat, Eva (author)
Dinney, Colin (author)
Otto, Wolfgang (author)
Shah, Jay (author)
Thuerof, Joachim (author)
Witjes, J. Alfred (author)
show less...
 (creator_code:org_t)
Elsevier BV, 2013
2013
English.
In: European Urology. - : Elsevier BV. - 1873-7560 .- 0302-2838. ; 63:1, s. 36-44
  • Research review (peer-reviewed)
Abstract Subject headings
Close  
  • Context: Our aim was to present a summary of the Second International Consultation on Bladder Cancer recommendations on the diagnosis and treatment options for non-muscle-invasive urothelial cancer of the bladder (NMIBC) using an evidence-based approach. Objective: To critically review the recent data on the management of NMIBC to arrive at a general consensus. Evidence acquisition: A detailed Medline analysis was performed for original articles addressing the treatment of NMIBC with regard to diagnosis, surgery, intravesical chemotherapy, and follow-up. Proceedings from the last 5 yr of major conferences were also searched. Evidence synthesis: The major findings are presented in an evidence-based fashion. We analyzed large retrospective and prospective studies. Conclusions: Urothelial cancer of the bladder staged Ta, T1, and carcinoma in situ (CIS), also indicated as NMIBC, poses greatly varying but uniformly demanding challenges to urologic care. On the one hand, the high recurrence rate and low progression rate with Ta low-grade demand risk-adapted treatment and surveillance to provide thorough care while minimizing treatment-related burden. On the other hand, the propensity of Ta high-grade, T1, and CIS to progress demands intense care and timely consideration of radical cystectomy. (C) 2012 European Association of Urology. Published by Elsevier B. V. All rights reserved.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Urologi och njurmedicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Urology and Nephrology (hsv//eng)

Keyword

Bacillus Calmette-Guerin (BCG)
Bladder cancer
Cystoscopy
Diagnosis
Guidelines
Intravesical chemotherapy
Prognosis
Transurethral
resection (TUR)

Publication and Content Type

for (subject category)
ref (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view